InvestorsHub Logo
Followers 0
Posts 51
Boards Moderated 0
Alias Born 02/27/2013

Re: Chicag0 post# 3347

Wednesday, 06/25/2014 5:48:41 PM

Wednesday, June 25, 2014 5:48:41 PM

Post# of 4817
I believe it's just due to the fact that ATRS is not a sexy biotech with some multi billion dollar cancer cure. This is a slow steady pipeline play that I believe will bear fruit as we get closer to 2016.

Fair disclosure, I bought calls today as I feel the worst of news is priced in and over. We were last at $2.75 when the company was AIS and Otrexup wasn't approved and QST wasn't enrolled.